Prevention FAQ — FMCSR 382.215: Positive Drug Test Operating CMV

Inspectors do not conduct drug tests at the roadside; 382.215 citations arise from verified positive results generated through your fleet's DOT drug-testing program or from prior enforcement actions. Our inspection database shows zero citations for 382.215 across 13 million records, meaning citations almost never result from roadside discovery alone. Instead, inspectors flag this violation when they access your carrier's drug-testing records during compliance reviews or when a driver self-reports a positive result. Your role is ensuring that any driver with a verified positive is immediately removed from duty and that all testing documentation is audit-ready. Inspectors will scrutinize test chain-of-custody, lab certifications, and your response protocol—not the roadside inspection itself.

No. 382.215 describes a regulatory consequence (operating after a positive test), not a condition drivers can inspect before departure. Your pre-trip checklist cannot prevent this violation because it is rooted in the drug-testing program, not vehicle condition. Instead, focus your checklist and daily briefing on driver fitness for duty: ensure drivers understand that any use of prohibited controlled substances disqualifies them from operating. The violation prevention strategy sits upstream—in your testing program's accuracy, your medical review officer's credentials, and your immediate removal-from-duty protocol when a positive is confirmed. Your safety team should audit testing procedures monthly, not pre-trip inspections.

Drivers must carry evidence of their DOT medical certification and any negative test results if your fleet policy requires proof during roadside stops (though not federally mandated). The carrier must retain: (1) copies of all drug test results (positive and negative) for all drivers for 1 year minimum; (2) chain-of-custody documentation for each test; (3) Medical Review Officer (MRO) determinations and any verification of positive results; (4) written notification to the driver of a positive result and the removal-from-duty action; (5) any split-sample test results if the driver requested one. Keep these records in a secure, searchable database—not paper files. Inspectors will request these during compliance audits, and gaps in documentation can lead to additional violations beyond the positive test itself.

Our data shows 382.215 has never been cited in 13 million inspections, but peer violations in controlled substances and alcohol paint a critical pattern. The top co-occurring codes are 392.4A-DOSP (Use of drugs, 3,947 citations at 95.9% OOS) and 392.4(a) (Use of drugs, 3,919 citations at 96.9% OOS). These codes describe on-duty or operational drug use—not test results—suggesting that drivers cited for active drug use often have prior positive tests unaddressed by their carrier. The presence of alcohol-related codes (392.5(a)(2), 99.2% OOS) alongside drug violations indicates systemic driver-hiring or monitoring failures. Root-cause analysis should examine: (1) Are you pre-employment testing all candidates? (2) Are you removing positive-test drivers immediately? (3) Is your MRO process documented and compliant?

A driver with a verified positive result must not return to service without: (1) a written return-to-duty evaluation by a DOT-certified substance abuse professional (SAP); (2) a negative result on a return-to-duty test; and (3) a minimum of six unannounced follow-up tests over 12 months. Before the driver operates any CMV again, confirm with your MRO that the positive test was not challenged successfully and that no split-sample exonerated the driver. Document the SAP evaluation and test results in your carrier file. Do not rely on the driver's verbal assurance or a single negative test. Your safety manager should personally verify the return-to-duty file is complete before authorizing re-qualification. Any deviation from this process exposes the carrier to liability and potential 382.215 citations.

Although 382.215 citations are extremely rare in roadside enforcement, if your carrier receives one, immediate actions include: (1) confirm the positive test occurred and the driver's identity; (2) verify the MRO determined the result was positive (not challenged or cancelled); (3) review whether the driver was operating post-positive (the violation itself); (4) audit your drug-testing program for gaps—test intervals, MRO credentials, chain-of-custody failures; (5) interview the driver about when they learned of the positive and why they continued operating; (6) check whether your fleet safety manager was notified in real-time. Use this as a trigger to audit all active drivers' test histories—if one positive slipped through, others may have too. Document findings and corrective actions (e.g., improved MRO protocols, faster removal-from-duty messaging) in writing and share with your DOT compliance team.

A 382.215 citation does not affect the Vehicle Maintenance BASIC; it falls under the Controlled Substances/Alcohol BASIC (BASIC 4) with a severity weight of 10. Unlike mechanical defects, this violation is tied to driver conduct and drug-testing program management. However, the high severity weight (10) means even a single citation generates substantial CSA points. Across our 13 million inspections, 382.215 has never been cited, which reflects the rarity of this specific code being discovered at roadside. If your fleet receives one, your BASIC 4 score will rise immediately. Prevention requires a robust, documented drug-testing program—monthly MRO audits, real-time removal-from-duty protocols, and return-to-duty SAP evaluations—not vehicle repairs.

Focus driver training on: (1) Understanding prohibited controlled substances (legal prescription use vs. prohibited use); (2) DOT drug-testing program mechanics—what triggers a test (pre-employment, random, post-accident, reasonable suspicion), how chain-of-custody works, and the driver's rights in split-sample requests; (3) The immediate consequence of a positive result—removal from duty, no exceptions, and the return-to-duty process; (4) The legal liability: operating after a verified positive is a 382.215 violation with a severity weight of 10 and potential out-of-service placement; (5) Practical scenarios—if a driver is notified of a positive result, they must stop operating immediately and inform the safety manager. Annual refresher training should include case studies from your peer carriers in your state. Emphasize that this is not a 'second-chance' situation; the violation occurs the moment a driver operates post-positive.

A DataQs challenge is warranted only if: (1) the drug test was not properly verified by your MRO (e.g., the lab failed to follow chain-of-custody); (2) your carrier was not the employer of record at the time of the test; (3) the driver's identity was mismatched; or (4) the citation was issued to the wrong carrier. Do not challenge the citation simply because the driver disputes the positive result—that is a split-sample or MRO re-review issue, not a DataQs matter. Our 13 million records show zero 382.215 citations ever issued, so if you receive one, verify first that it is correctly attributed to your carrier and driver before filing a challenge. Consult your legal counsel and MRO immediately if you believe an error occurred. Frivolous challenges waste resources.

Audit monthly. Our inspection data shows zero 382.215 citations in the last 90 days and last 12 months across 13 million records, indicating this violation is caught almost exclusively through carrier-level audits and DOT compliance reviews, not roadside inspections. A monthly audit should verify: (1) all required pre-employment tests were conducted and documented; (2) random testing pool includes all drivers at the required percentage; (3) MRO determinations are issued within regulatory timelines; (4) any positive results triggered immediate removal from duty; (5) return-to-duty SAP evaluations are complete before drivers resume operations; (6) follow-up testing is scheduled for drivers re-qualified after a positive. Document each audit in writing. This cadence catches errors before they result in a driver operating post-positive. Quarterly deep-dive reviews of testing records—comparing what your carrier claims vs. what labs report—add a secondary control layer.